Pharma-Bio Serv, Inc. (PBSV)
About Pharma-Bio Serv, Inc.
PHARM-BIO SERV INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $9.0M
- Net income
- -$100.5K
- Total assets
- $13.7M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Dividend yield
- 17.86%
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Pharma-Bio Serv, Inc. (PBSV) Stock Price
- Reported a net loss of $100.5K in FY2025.
- Trading 39% below its 52-week high.
- Pays a dividend yielding about 17.86% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Pharma-Bio Serv, Inc..
Write a review
Pharma-Bio Serv, Inc.: frequently asked questions
Is Pharma-Bio Serv, Inc. an American company?
Pharma-Bio Serv, Inc. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Pharma-Bio Serv, Inc. publicly traded?
Yes — Pharma-Bio Serv, Inc. is a publicly traded company. Its stock trades under the ticker symbol PBSV on the OTC.
What does Pharma-Bio Serv, Inc. do?
Pharma-Bio Serv, Inc. is an American Professional Services company in the Business & Financial Services sector.
